| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/NEN.0B013E31824B27E4 |
| P953 | full work available online at | https://academic.oup.com/jnen/article-pdf/71/4/289/9561855/71-4-289.pdf |
| https://doi.org/10.1097/nen.0b013e31824b27e4 | ||
| https://europepmc.org/articles/PMC3419254 | ||
| https://europepmc.org/articles/PMC3419254?pdf=render | ||
| P932 | PMC publication ID | 3419254 |
| P698 | PubMed publication ID | 22437340 |
| P50 | author | Peter Szatmari | Q7177216 |
| Margaret Fahnestock | Q54301212 | ||
| Enrico Tongiorgi | Q87983707 | ||
| P2093 | author name string | Chiara Nicolini | |
| Guanhua Yu | |||
| Bernadeta Michalski | |||
| Diego J. Garzon | |||
| Kristine L. P. Garcia | |||
| Victor S. Chiu | |||
| P2860 | cites work | Copy-number variations associated with neuropsychiatric conditions | Q22251090 |
| Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism | Q24299042 | ||
| A functional role of postsynaptic density-95-guanylate kinase-associated protein complex in regulating Shank assembly and stability to synapses | Q24307991 | ||
| Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation | Q24312962 | ||
| Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders | Q24337114 | ||
| Functional impact of global rare copy number variation in autism spectrum disorders | Q24596191 | ||
| Neurotrophins: roles in neuronal development and function | Q24656166 | ||
| Structural variation of chromosomes in autism spectrum disorder | Q24656970 | ||
| Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization | Q24675925 | ||
| Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain | Q43657279 | ||
| Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study | Q43868387 | ||
| Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism | Q44381044 | ||
| Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia | Q44507092 | ||
| An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients | Q44570590 | ||
| Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity | Q45108268 | ||
| Face processing occurs outside the fusiform 'face area' in autism: evidence from functional MRI. | Q46066091 | ||
| Activation of p75NTR by proBDNF facilitates hippocampal long-term depression | Q46604995 | ||
| Serum neurotrophin concentrations in autism and mental retardation: a pilot study | Q47424215 | ||
| Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. | Q47724311 | ||
| Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia | Q48128316 | ||
| BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies | Q48159820 | ||
| Face recognition in human extrastriate cortex | Q48180475 | ||
| The neuropathology of the autism spectrum disorders: what have we learned? | Q48183213 | ||
| Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism | Q48248519 | ||
| Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys | Q48338739 | ||
| Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouse | Q48416143 | ||
| Neuropathology of Infantile Autism | Q48418627 | ||
| Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? | Q48436878 | ||
| A clinicopathological study of autism | Q48454065 | ||
| Endogenous BDNF Protein Is Increased in Adult Rat Hippocampus after a Kainic Acid Induced Excitotoxic Insult but Exogenous BDNF Is Not Neuroprotective | Q48512784 | ||
| Brain-derived neurotrophic factor is reduced in Alzheimer's disease | Q48591280 | ||
| Decreased serum brain-derived neurotrophic factor levels in major depressed patients | Q48642995 | ||
| Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses | Q48752188 | ||
| BDNF and epilepsy--the bad could turn out to be good | Q48831822 | ||
| Detection of increased tissue concentrations of nerve growth factor with an improved extraction procedure | Q48853672 | ||
| Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. | Q48871284 | ||
| Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy | Q50305480 | ||
| Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome | Q50313035 | ||
| Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice | Q52201421 | ||
| Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. | Q53234267 | ||
| Autism | Q73485572 | ||
| Mapping autism risk loci using genetic linkage and chromosomal rearrangements | Q27315912 | ||
| Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders | Q27861089 | ||
| Regulation of Cell Survival by Secreted Proneurotrophins | Q27919620 | ||
| The fusiform face area: a module in human extrastriate cortex specialized for face perception | Q28238243 | ||
| Autism as a strongly genetic disorder: evidence from a British twin study | Q28303915 | ||
| A genome-wide scan for common alleles affecting risk for autism | Q28943508 | ||
| The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
| Neuroglial activation and neuroinflammation in the brain of patients with autism | Q29619689 | ||
| A synaptic trek to autism | Q29622832 | ||
| BDNF and epilepsy: too much of a good thing? | Q31865271 | ||
| Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor | Q33932396 | ||
| Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses | Q33968304 | ||
| Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis | Q34132832 | ||
| fMRI activation of the fusiform gyrus and amygdala to cartoon characters but not to faces in a boy with autism | Q34393577 | ||
| Levels of categorization in visual recognition studied using functional magnetic resonance imaging | Q34438035 | ||
| BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis | Q34442760 | ||
| A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism | Q34557745 | ||
| Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain | Q34729750 | ||
| Recurrent 16p11.2 microdeletions in autism | Q34729775 | ||
| From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning | Q34931098 | ||
| Pro-region of neurotrophins: role in synaptic modulation | Q35209102 | ||
| Local effects of BDNF on dendritic growth | Q35808549 | ||
| Subplate neurons: a missing link among neurotrophins, activity, and ocular dominance plasticity? | Q36086819 | ||
| Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome | Q36313707 | ||
| Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. | Q37273874 | ||
| Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. | Q37346108 | ||
| A genome-wide linkage and association scan reveals novel loci for autism | Q37410600 | ||
| Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism | Q37460218 | ||
| Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation | Q38461332 | ||
| Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells | Q40161957 | ||
| ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. | Q40414334 | ||
| Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor | Q40832311 | ||
| An Acid-Treatment Method for the Enhanced Detection of GDNF in Biological Samples | Q41107033 | ||
| Physiology of the neurotrophins | Q41132669 | ||
| Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases | Q41229731 | ||
| Unfamiliar Face Recognition in Relatively Able Autistic Children | Q41775646 | ||
| Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. | Q42438737 | ||
| An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. | Q42472407 | ||
| Neurotrophins regulate dendritic growth in developing visual cortex | Q42479052 | ||
| The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease | Q42509117 | ||
| Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. | Q42956192 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| autism | Q38404 | ||
| P304 | page(s) | 289-297 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism | |
| Altered Balance of Proteolytic Isoforms of Pro-Brain-Derived Neurotrophic Factor in Autism | |||
| P478 | volume | 71 |
| Q64067519 | A Functional Polymorphism (rs6265, G>A) of Brain-Derived Neurotrophic Factor Gene and Breast Cancer: An Association Study |
| Q36361793 | A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays |
| Q36874302 | A pilot open-label trial of minocycline in patients with autism and regressive features |
| Q50301293 | Altered cytokine and BDNF levels in autism spectrum disorder. |
| Q89920725 | BDNF Expression in Cortical GABAergic Interneurons |
| Q33892169 | Bio-collections in autism research |
| Q36549135 | Brain-Derived Neurotrophic Factor Expression in Asthma. Association with Severity and Type 2 Inflammatory Processes. |
| Q39110745 | Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis. |
| Q26795382 | Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions |
| Q35017799 | Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid |
| Q33676486 | Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome |
| Q58565218 | Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells |
| Q37237028 | Epigenetic findings in autism: new perspectives for therapy |
| Q36923821 | Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity |
| Q47134578 | Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study. |
| Q50308164 | Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families |
| Q64102163 | Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers? |
| Q58698270 | Mechanism of BDNF Modulation in GABAergic Synaptic Transmission in Healthy and Disease Brains |
| Q64062979 | Mechanisms That Modulate and Diversify BDNF Functions: Implications for Hippocampal Synaptic Plasticity |
| Q48045959 | Meta-Analysis of BDNF Levels in Autism |
| Q38027374 | MicroRNAs: A Light into the “Black Box” of Neuropediatric Diseases? |
| Q53402655 | Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation. |
| Q36558162 | Pilot Study and Review: Physiological Differences in BDNF, a Potential Biomarker in Males and Females with Autistic Disorder |
| Q91623537 | Pioglitazone abolishes cognition impairments as well as BDNF and neurotensin disturbances in a rat model of autism |
| Q50003376 | Prenatal paracetamol exposure and child neurodevelopment: a review |
| Q48408039 | Pro-Brain-Derived Neurotrophic Factor (proBDNF)-Mediated p75NTR Activation Promotes Depolarizing Actions of GABA and Increases Susceptibility to Epileptic Seizures |
| Q35175633 | Sera from children with autism induce autistic features which can be rescued with a CNTF small peptide mimetic in rats |
| Q39168780 | Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury |
| Q38162501 | The need for a comprehensive molecular characterization of autism spectrum disorders |
| Q55513493 | The pharmacological perturbation of brain zinc impairs BDNF-related signaling and the cognitive performances of young mice. |
| Q47171883 | The serine protease inhibitor neuroserpin is required for normal synaptic plasticity and regulates learning and social behavior |
| Q36636300 | Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques |
Search more.